YELLOW FEVER
Clinical trials for YELLOW FEVER explained in plain language.
Never miss a new study
Get alerted when new YELLOW FEVER trials appear
Sign up with your email to follow new studies for YELLOW FEVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New yellow fever vaccine shows promise in early trial
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested a new yellow fever vaccine (MVA-BN-YF) in 92 healthy adults aged 18-45. The goal was to check its safety and how well it triggers an immune response, with some groups also receiving an adjuvant to boost effectiveness. Results will help decide if furt…
Matched conditions: YELLOW FEVER
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 07:05 UTC
-
New yellow fever vaccine passes early safety check
⭐️ VACCINE ⭐️ CompletedThis early-stage trial tested a new inactivated yellow fever vaccine called HydroVax-002 YFV in 26 healthy adults aged 18 to 49. Participants received two shots 29 days apart at either a low or high dose, or a placebo. The main goal was to see if the vaccine is safe and to measur…
Matched conditions: YELLOW FEVER
Phase: PHASE1 • Sponsor: Najit Technologies, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 06:50 UTC
-
New vaccines for yellow fever and rabies enter first human tests
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested two new vaccines—one for yellow fever and one for rabies—in 112 healthy adults aged 18 to 40. The main goal was to check safety and how well the vaccines trigger an immune response. Participants received either the vaccine or a placebo, and researche…
Matched conditions: YELLOW FEVER
Phase: PHASE1 • Sponsor: AstriVax Therapeutics • Aim: ⭐️ VACCINE ⭐️
Last updated May 14, 2026 12:02 UTC
-
New yellow fever vaccine shows promise in japanese adults
⭐️ VACCINE ⭐️ CompletedThis study tested a new yellow fever vaccine (vYF) in 254 healthy adults aged 18 and older in Japan. Participants received one shot, and researchers checked their immune response and safety over about a month. The goal was to see if the vaccine triggers enough protection against …
Matched conditions: YELLOW FEVER
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 01, 2026 16:01 UTC
-
Scientists use yellow fever shot to map immune system's viral battle plan
Knowledge-focused CompletedThis study gave 239 healthy adults the yellow fever vaccine to learn how the immune system reacts to a real viral infection. The vaccine is safe and effective, making it a good model for studying immune responses. Participants were followed for up to one year to measure their T c…
Matched conditions: YELLOW FEVER
Phase: PHASE4 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 17, 2026 06:47 UTC
-
Scientists probe why some people lose vaccine protection after yellow fever shot
Knowledge-focused CompletedThis study looked at how past infections and damage to lymph nodes might weaken the body's long-term immune response to the yellow fever vaccine. Researchers enrolled 43 healthy adults in Uganda and Minnesota, collecting blood and lymph node samples before and after vaccination. …
Matched conditions: YELLOW FEVER
Phase: PHASE1, PHASE2 • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated May 07, 2026 18:42 UTC